We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$201M
AUM Growth
+$21.6M
Cap. Flow
+$4.01M
Cap. Flow %
2%
Top 10 Hldgs %
34.54%
Holding
94
New
3
Increased
25
Reduced
34
Closed
3

Top Buys

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$1.45M
2
QCOM icon
Qualcomm
QCOM
+$1.25M
3
GSK icon
GSK
GSK
+$958K
4
JCI icon
Johnson Controls International
JCI
+$689K
5
SLB icon
SLB Ltd
SLB
+$507K

Sector Composition

Rank Sector Weight
1 Healthcare 22.57%
2 Industrials 18.92%
3 Technology 17.72%
4 Energy 14.64%
5 Consumer Staples 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RY icon
76
Royal Bank of Canada
RY
$292B
$202K 0.1%
3,000
-118
-4% -$7.82K
ETN icon
77
Eaton
ETN
$156B
$201K 0.1%
+2,628
New +$187K
VSTM icon
78
Verastem
VSTM
$505M
$114K 0.06%
+833
New +$109K
ECT
79
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$78K 0.04%
10,100
-14,500
-59% -$125K
FTR
80
DELISTED
Frontier Communications Corp.
FTR
$60K 0.03%
867
DVN icon
81
Devon Energy
DVN
$50.5B
-8,905
Closed -$514K
OVV icon
82
Ovintiv
OVV
$16.2B
-3,177
Closed -$276K
PWE
83
DELISTED
Penn West Energy Petroleum Ltd
PWE
-10,100
Closed -$113K

Similar funds

Brian C. Broderick's Q4 2013 Portfolio in Review

As of Q4 2013, Brian C. Broderick held 94 positions worth $201M, up 12% from $179M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Brian C. Broderick's Q4 2013 filing shows 3 new, 25 increased, 34 reduced and 3 closed positions. Its largest new stake was Epizyme, Inc: 50,000 shares worth $1.04M. The largest sale was Teva Pharmaceuticals, an estimated $720K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Brian C. Broderick's largest Q4 2013 buy was Epizyme, Inc: 50,000 shares worth $1.04M.
  • Brian C. Broderick added most to Qualcomm in Q4 2013, an estimated $1.25M increase.
  • Brian C. Broderick's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $720K.
  • Brian C. Broderick fully exited Devon Energy in Q4 2013, selling an estimated $514K.
  • Brian C. Broderick's ten largest holdings make up 35% of its $201M portfolio in Q4 2013.
  • Brian C. Broderick opened 3 new positions and closed 3 in Q4 2013.
  • Brian C. Broderick's portfolio value rose 12% quarter-over-quarter to $201M.

Based on Brian C. Broderick's 13F filing for Q4 2013, filed 27 Feb 2014.